Derivatives if imidazol (1,5-a) pyridin-3 (2H) -one
Palazzo, G.; Picconi, G.
Il Farmaco; Edizione Scientifica 30(3): 197-207
1975
ISSN/ISBN: 0430-0920 PMID: 1116598 Document Number: 92796
Numerous imidazo[1,5-a]pyridin-3(2H)-one derivatives having one or two electron-attracting substituents in positions 1 or 2 have been prepared starting from substituted 2-aminomethyl-pyridines and phosgene or ethyl chlorocarbonate. Attempts to obtain unsubstituted imidazo[1,5-a]-pyridin-3(2H)-one were not successful.
Document emailed within 1 workday
Related Documents
Nantka-Namirski, P.; Piechaczek, J.; Wrotek, J. 1976: Synthesis of derivatives of 1,2,3,4-tetrahydro-5H-(1) benzopyrano (2,3-b) pyridin-5-one Acta Poloniae Pharmaceutica 33(6): 669-672Malhotra, M.; Hans, P.; Sharma, S.; Deep, A.; Phogat, P. 2012: Synthesis and characterization of (Z)-N-(1-[2-{3-[(dimethylamino)methyl)]-2-methoxyphenyl}-5-(pyridin-4-yl)-1,3,4-oxadiazol-3(2H)-yl]ethylidene) benzenamine derivatives as potent antifungal agents Acta Poloniae Pharmaceutica 69(3): 433-438
Silvestri, R.; Pagnozzi, E.; Troccoli, F.; Stefancich, G.; Massa, S.; Apuzzo, G.; Perazzi, M.E.; Artico, M.; Simonetti, G. 1995: Antifungal agents. 10. Synthesis and antifungal activities of aryl-(1H-imidazol-1-yl)-(isoquinolin-1-yl) methane derivatives Farmaco 50(4): 227-238
Mantovani, P.; Impicciatore, M. 1970: Some pharmacological activities of 2,6-bis-(hydroxymethyl)pyridin-bis-(N-methylcarbamate) (Pyridinolcarbamate) Il Farmaco; Edizione Scientifica 25(12): 912-919
Wujec, M.; Pitucha, M.; Dobosz, M. 2004: Synthesis of 1-substituted-4-ethyl-3-(pyridin-3-yl)-1,2,4-triazoline-5-thione Acta Poloniae Pharmaceutica 61 Suppl: 13-15
Dautova, G.S.; Kosykh, V.A.; Repin, V.S.; Kamburg, R.A. 1994: The effect of dimethyl-(imidazol-1-yl) methanesulfonic acid on experimental atherogenesis in rabbits Eksperimental'naia i Klinicheskaia Farmakologiia 57(5): 21-24
Srivastava, V.K.; Singh, S.; Palit, G.; Shanker, K. 1986: 1-[4-(4,5-dihydro-1H-imidazol-2-yl)aminophenyl]-3-(substituted phenyl)-2-propene-1-one as antiparkinsonian agents Die Pharmazie 41(8): 598-599
Terai, T.; Kusunoki, T.; Kita, Y.; Yoshida, K.; Akahane, A.; Shiokawa, Y.; Kohno, Y.; Horiai, H.; Mori, J.; Mine, Y.; Kohsaka, M. 1996: General pharmacology of the new non-xanthine adenosine A1 receptor antagonist (+)-(R)-[(E)-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)acryloyl]-2- piperidine ethanol Arzneimittel-Forschung 46(2): 185-191
Bandoh, K.; Ishizuka, Y.; Sato, M. 1995: Effects of 3-[N-(2-chlorobenzyl)amino]-6-(1H-imidazol-1-yl) pyridazine dihydrochloride on various aromatase enzyme systems and experimental breast cancer Arzneimittel-Forschung 45(8): 897-900
Terazawa, K.; Watanabe, K.; Terabayashi, M.; Kuramoto, S.; Yokomoto, Y.; Otani, K.; Shimamura, K.; Yamashita, K. 1992: Acute toxicity study of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl) amino] benzoate dimethanesulfonate (FUT-187) in mice, rats and dogs Journal of Toxicological Sciences 17 Suppl 4(6): 1-15
Chen, C.L.; Sangiah, S.; Roder, J.D.; Chen, H.; Berlin, K.D.; Garrison, G.L.; Scherlag, B.J.; Lazzara, R. 1995: Pharmacokinetics and plasma protein binding of the new potent class IIi antiarrhythmic agent 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3, 7-diazabicyclo[3.3.1]nonane dihydroperchlorate Arzneimittel-Forschung 45(6): 670-675
Kowaluk, E.A.; Mikusa, J.; Wismer, C.T.; Zhu, C.Z.; Schweitzer, E.; Lynch, J.J.; Lee, C.H.; Jiang, M.; Bhagwat, S.S.; Gomtsyan, A.; McKie, J.; Cox, B.F.; Polakowski, J.; Reinhart, G.; Williams, M.; Jarvis, M.F. 2000: ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. in vivo characterization in the rat Journal of Pharmacology and Experimental Therapeutics 295(3): 1165-1174
Coudert, P.; Rubat, C.; Couquelet, J.; Tronche, P. 1990: Synthesis of 6-[(4-imidazol-1-yl)-phenyl]-4-phenyl 4,5-dihydro-2H-pyridazin-3-one: a potential blood platelet aggregation inhibitor Journal de Pharmacie de Belgique 45(3): 191-195
Lukasiak, J.; Radecki, A.; Jamrógiewicz, Z. 1977: Silicone derivatives of medicinal agents. XI. Methylsilyl derivatives of methyl and propyl p-hydroxybenzoate Acta Poloniae Pharmaceutica 34(6): 615-620
Mazzei, M.; Roma, G.; Ermili, A.; Cacciatore, C. 1979: Chemical and pharmacological research on pyran derivatives. XIII. Derivatives of 2H-pyrano/3,2-c/quinoline Il Farmaco; Edizione Scientifica 34(6): 469-477
Albrecht, B.; Bräuniger, H. 1972: Formation of heterocyclic derivatives from (2- or 3-methyl-phenothiazinyl-(10))-propionic acid. 17. Phenothiazine derivatives Die Pharmazie 27(5): 282-287
Foks, H.; Janowiec, M. 1978: Pyrazine derivatives. XI. Synthesis and tuberculostatic activity of derivatives of pyrazineurea and pyrazinethiourea Acta Poloniae Pharmaceutica 35(5): 615-618
Achilova, G.S.; Auelbekov, S.A.; Aslanov, K.A.; Barinskiĭ, I.F. 1989: Antiviral activity of derivatives of aldehydophenols, aldehydo- naphthols and sugar derivatives Voprosy Virusologii 34(3): 315-319
Roma, G.; Di Braccio, M.; Grossi, G.; Marzano, C.; Simonato, M.; Bordin, F. 1998: Pyran derivatives. XX. 2-Aminochromone benzo-fused derivatives with antiproliferative properties Farmaco 53(7): 494-503
Milczarska, B.; Foks, H.; Trapkowski, Z.; Milzyńska-Kołaczek, A.; Janowiec, M.; Zwolska, Z.; Andrzejczyk, Z. 1998: Studies on pyrazine derivatives. XXXII. Synthesis and tuberculostatic activity of acetylpyrazine thiosemicarbazone derivatives Acta Poloniae Pharmaceutica 55(4): 289-295